Evofem Biosciences (NASDAQ:EVFM) Stock Passes Below 200-Day Moving Average – Should You Sell?

Evofem Biosciences, Inc. ( NASDAQ:EVFM – Get Free Report )’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.

01 and traded as low as $0.01. Evofem Biosciences shares last traded at $0.



01, with a volume of 49,531 shares changing hands. Evofem Biosciences Stock Performance The firm has a market capitalization of $1.01 million, a PE ratio of -0.

01 and a beta of -0.87. The stock’s 50-day simple moving average is $0.

01 and its 200-day simple moving average is $0.01. Evofem Biosciences Company Profile ( Get Free Report ) Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health.

Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis. Read More Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.

com's FREE daily email newsletter ..